• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. FMC BLOODLINES; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. FMC BLOODLINES; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Device Problems Fluid/Blood Leak (1250); Device Maintenance Issue (1379)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/15/2015
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Plant investigation is in process.A supplemental mdr will be submitted upon the completion of this activity.
 
Event Description
A hemodialysis patient reported a full circuit of blood was lost during hemodialysis treatment.The exact event date was not known, but was reported as having occurred in the middle of (b)(6).The blood tubing set was discarded without a return of the blood within the circuit.The patient's estimated blood loss from the discarded circuit was approximately 300cc.Follow-up information was requested from the site clinical manager who revealed that an adverse event form would be filed by the clinical staff if an event occurred which required that a bloodline be disposed of with blood remaining in the lines.She confirmed there had been no recent adverse events documented which could be related to the incident reported by this caller.As such, no further information is available related to this event.Additionally, as the caller chose to remain anonymous, medical records are not available and no further case details can be gathered.
 
Manufacturer Narrative
The device was not returned nor was a companion sample available to the manufacturer for physical evaluation.No malfunction was confirmed during evaluation of the alternate samples.A manufacturing review was performed of the products shipped to the dialysis center for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all bloodline tubing sets shipped to this account within the selected time frame.A records review was performed on each identified lot.An investigation of the device manufacturing records was conducted by the manufacturer.There were no deviations or non-conformances during the manufacturing process.In addition, the batch record review confirmed the labeling, material, and process controls were within specification.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FMC BLOODLINES
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa, tamaulipas cp 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa, tamaulipas cp 88780
MX   88780
Manufacturer Contact
tanya taft
920 winter st.
waltham, MA 02451
7816999000
MDR Report Key5433968
MDR Text Key38700026
Report Number8030665-2016-00057
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup
Report Date 03/03/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/12/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received02/09/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-